Synthesis and biological evaluation of a novel decadentate ligand DEPA.

[1]  M. Brechbiel,et al.  Novel synthetic ligands for targeted PET imaging and radiotherapy of copper. , 2007, Bioorganic & medicinal chemistry letters.

[2]  C. Anderson,et al.  Copper chelation chemistry and its role in copper radiopharmaceuticals. , 2007, Current pharmaceutical design.

[3]  N. Birch,et al.  Iron chelators as therapeutic iron depletion agents , 2006 .

[4]  M. Brechbiel,et al.  In vitro and in vivo evaluation of novel ligands for radioimmunotherapy. , 2006, Nuclear medicine and biology.

[5]  M. Brechbiel,et al.  Synthesis and evaluation of novel macrocyclic and acyclic ligands as contrast enhancement agents for magnetic resonance imaging. , 2006, Journal of medicinal chemistry.

[6]  W. Wong,et al.  A selective one-step synthesis of tris N-alkylated cyclens , 2004 .

[7]  M. Brechbiel,et al.  Antibody-targeted radiation cancer therapy , 2004, Nature Reviews Drug Discovery.

[8]  S. Jurisson,et al.  Aminocarboxylate complexes and octreotide complexes with no carrier added 177Lu, 166Ho and 149Pm. , 2003, Nuclear medicine and biology.

[9]  M. Brechbiel,et al.  Synthesis and biological evaluation of novel macrocyclic ligands with pendent donor groups as potential yttrium chelators for radioimmunotherapy with improved complex formation kinetics. , 2002, Journal of medicinal chemistry.

[10]  E. Dadachova,et al.  Recent advances in radionuclide therapy. , 2001, Seminars in nuclear medicine.

[11]  M. Brechbiel,et al.  The development of the alpha-particle emitting radionuclides 212Bi and 213Bi, and their decay chain related radionuclides, for therapeutic applications. , 2001, Chemical reviews.

[12]  I. Pastan,et al.  Synthesis and evaluation of a macrocyclic bifunctional chelating agent for use with bismuth radionuclides. , 2001, Nuclear medicine and biology.

[13]  R. Lauffer,et al.  Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications. , 1999, Chemical reviews.

[14]  A. Sherry,et al.  Synthesis and characterization of 1,4,7-triazacyclononane derivatives with methylphosphinate and acetate side chains for monitoring free MgII by31P and1H NMR spectroscopy , 1996 .

[15]  Matthew A. Williams,et al.  Synthesis of enantiomerically pure diethylenetriaminepentaacetic acid analogs. L-Phenylalanine as the educt for substitution at the central acetic acid , 1993 .

[16]  T. Koike,et al.  Thermodynamic and kinetic studies of lanthanide complexes of 1,4,7,10,13-pentaazacyclopentadecane-N,N',N'',N''',N''''-pentaacetic acid and 1,4,7,10,13,16-hexaazacyclooctadecane-N,N',N'',N''',N'''',N'''''-hexaacetic acid , 1991 .

[17]  R. D. Shannon.  Revised effective ionic radii and systematic studies of interatomic distances in halides and chalcogenides , 1976 .

[18]  S. B. Savvin.  Analytical use of arsenazo III: Determination of thorium, zirconium, uranium and rare earth elements , 1961 .